Literature DB >> 23892469

Wharton's jelly-derived mesenchymal stem cells promote myocardial regeneration and cardiac repair after miniswine acute myocardial infarction.

Wei Zhang1, Xiao-Cheng Liu, Li Yang, De-Lin Zhu, Ya-Dong Zhang, Yue Chen, Hai-Yan Zhang.   

Abstract

OBJECTIVE: To investigate the therapeutic effects of Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) on myocardial regeneration and cardiac repair after acute myocardial infarction (AMI).
MATERIALS AND METHODS: WJ-MSCs were isolated from human umbilical cord under sterile conditions and were cultured and expanded until passage 5. WJ-MSCs were labeled with CM-Dil before transplantation. The mid-third of the left anterior descending artery was ligated surgically to establish a mini-swine AMI model. The miniswines were divided randomly into three groups (n=6 in each): control group, PBS group, and transplantation group. Six weeks later, evaluation of the changes in myocardial perfusion and function was performed by single-photon emission computed tomography and echocardiography in each group. Then, the animals were euthanized and the tissues in the infarcted area were harvested for histopathological examination.
RESULTS: The changes in myocardial perfusion and function were significantly improved in the transplantation group compared with the control and PBS groups (P<0.001). Immunofluorescence results confirmed that the transplanted WJ-MSCs were still alive and part of them appeared to have differentiated into cardiomyocytes and vascular endothelia 6 weeks after transplantation. In the meantime, it was also observed that resident cardiac stem cells also recruited and differentiated into neonatal cardiomyocytes and vascular endothelia. Masson's trichrome showed more viable myocardium and less fibrous tissue in the transplantation group compared with the other two groups (P<0.001). Vessel density was augmented and cell apoptosis was reduced in the transplantation group compared with the control and PBS groups (P<0.001).
CONCLUSION: WJ-MSCs transplanted by a direct injection into the infarcted area could survive and differentiate into cardiomyocytes and endothelial cells. They also promoted recruitment and differentiation of cardiac stem cells in a porcine model with AMI. In addition, WJ-MSC transplantation reduced apoptosis and fibrosis, enhanced viable myocardium, and thus improved ventricular remodeling and function.

Entities:  

Mesh:

Year:  2013        PMID: 23892469     DOI: 10.1097/MCA.0b013e3283640f00

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  28 in total

Review 1.  Preclinical Studies of Stem Cell Therapy for Heart Disease.

Authors:  Bryon A Tompkins; Wayne Balkan; Johannes Winkler; Mariann Gyöngyösi; Georg Goliasch; Francisco Fernández-Avilés; Joshua M Hare
Journal:  Circ Res       Date:  2018-03-30       Impact factor: 17.367

2.  Human Umbilical Cord Mesenchymal Stromal Cell Transplantation in Myocardial Ischemia (HUC-HEART Trial). A Study Protocol of a Phase 1/2, Controlled and Randomized Trial in Combination with Coronary Artery Bypass Grafting.

Authors:  Alp Can; Ahmet Tulga Ulus; Ozgur Cinar; Ferda Topal Celikkan; Erdal Simsek; Mesut Akyol; Ugur Canpolat; Murat Erturk; Fadil Kara; Osman Ilhan
Journal:  Stem Cell Rev Rep       Date:  2015-10       Impact factor: 5.739

3.  Mesenchymal Stem Cell Deformability and Implications for Microvascular Sequestration.

Authors:  Herbert H Lipowsky; Daniel T Bowers; Brittany L Banik; Justin L Brown
Journal:  Ann Biomed Eng       Date:  2018-01-19       Impact factor: 3.934

Review 4.  Perspectives of induced pluripotent stem cells for cardiovascular system regeneration.

Authors:  Mária Csöbönyeiová; Štefan Polák; L'uboš Danišovič
Journal:  Exp Biol Med (Maywood)       Date:  2015-01-16

Review 5.  Emerging Trends in Mesenchymal Stem Cells Applications for Cardiac Regenerative Therapy: Current Status and Advances.

Authors:  Akriti Sharma; Santosh Gupta; S Archana; Rama Shanker Verma
Journal:  Stem Cell Rev Rep       Date:  2022-02-04       Impact factor: 5.739

6.  Human Umbilical Cord-Derived Mesenchymal Stromal Cells Improve Left Ventricular Function, Perfusion, and Remodeling in a Porcine Model of Chronic Myocardial Ischemia.

Authors:  Chuan-Bin Liu; He Huang; Ping Sun; Shi-Ze Ma; An-Heng Liu; Jian Xue; Jin-Hui Fu; Yu-Qian Liang; Bing Liu; Dong-Ying Wu; Shuang-Hong Lü; Xiao-Zhong Zhang
Journal:  Stem Cells Transl Med       Date:  2016-06-22       Impact factor: 6.940

7.  Intracoronary infusion of Wharton's jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial.

Authors:  Lian R Gao; Yu Chen; Ning K Zhang; Xi L Yang; Hui L Liu; Zhi G Wang; Xiao Y Yan; Yu Wang; Zhi M Zhu; Tian C Li; Li H Wang; Hai Y Chen; Yun D Chen; Chao L Huang; Peng Qu; Chen Yao; Bin Wang; Guang H Chen; Zhong M Wang; Zhao Y Xu; Jing Bai; Di Lu; Yan H Shen; Feng Guo; Mu Y Liu; Yong Yang; Yan C Ding; Ye Yang; Hai T Tian; Qing A Ding; Li N Li; Xin C Yang; Xiang Hu
Journal:  BMC Med       Date:  2015-07-10       Impact factor: 8.775

8.  Myocardial regeneration strategy using Wharton's jelly mesenchymal stem cells as an off-the-shelf 'unlimited' therapeutic agent: results from the Acute Myocardial Infarction First-in-Man Study.

Authors:  Piotr Musialek; Adam Mazurek; Danuta Jarocha; Lukasz Tekieli; Wojciech Szot; Magdalena Kostkiewicz; R Pawel Banys; Malgorzata Urbanczyk; Andrzej Kadzielski; Mariusz Trystula; Jacek Kijowski; Krzysztof Zmudka; Piotr Podolec; Marcin Majka
Journal:  Postepy Kardiol Interwencyjnej       Date:  2015-06-22       Impact factor: 1.426

9.  Human umbilical cord tissue-derived mesenchymal stromal cells attenuate remodeling after myocardial infarction by proangiogenic, antiapoptotic, and endogenous cell-activation mechanisms.

Authors:  Diana Santos Nascimento; Diogo Mosqueira; Luís Moura Sousa; Mariana Teixeira; Mariana Filipe; Tatiana Pinho Resende; Ana Francisca Araújo; Mariana Valente; Joana Almeida; José Paulo Martins; Jorge Miguel Santos; Rita Nogueira Bárcia; Pedro Cruz; Helder Cruz; Perpétua Pinto-do-Ó
Journal:  Stem Cell Res Ther       Date:  2014-01-10       Impact factor: 6.832

10.  Monocyte Chemoattractant Protein-Induced Protein 1 (MCPIP1) Enhances Angiogenic and Cardiomyogenic Potential of Murine Bone Marrow-Derived Mesenchymal Stem Cells.

Authors:  Anna Labedz-Maslowska; Barbara Lipert; Dominika Berdecka; Sylwia Kedracka-Krok; Urszula Jankowska; Elzbieta Kamycka; Malgorzata Sekula; Zbigniew Madeja; Buddhadeb Dawn; Jolanta Jura; Ewa K Zuba-Surma
Journal:  PLoS One       Date:  2015-07-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.